Back to Search Start Over

A small bowel adenocarcinoma harboring a DDR2 mutation in a celiac patient.

Authors :
Mollica L
Quaquarini E
Schiepatti A
Travaglino E
Antoci F
Vanoli A
Arpa G
Biagi F
Locati LD
Source :
Clinical journal of gastroenterology [Clin J Gastroenterol] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.
Publication Year :
2024
Publisher :
Ahead of Print

Abstract

We present the case of a 62-year-old man with a history of celiac disease and IgA deficiency, following a strict gluten-free diet that was admitted to our hospital for recurrent abdominal pain, fatigue and melena. Esophagogastroduodenoscopy and colonoscopy with biopsies were normal. A video-capsule endoscopy was performed and revealed a sub-stenosing, vegetating, and bleeding lesion in the first jejunal loop. He underwent laparotomic surgery with resection of the involved segment with loco-regional lymphadenectomy. The pathological report described a poorly differentiated adenocarcinoma of the jejunum, stage IIIA (pT3pN1). Analysis of next-generation sequencing (NGS) of DNA on the surgical sample revealed a likely pathogenetic variant in exon 15 of the DDR2 gene (c.2003G > A) and a TP53 non-frame-shift deletion (c.585_602del). Considering the risk of recurrence, he was candidate to 6 months of adjuvant chemotherapy with platinum salt and fluoropyrimidine. Thirty-eight months after the diagnosis, the patient is still disease free and in good clinical condition. This is the first described case of SBA with DDR2 mutation. Considering the limited therapeutic options beyond surgery for SBA, molecular analyses could become promising for the search for potential targetable alterations for treatments with new available drugs.<br /> (© 2024. Japanese Society of Gastroenterology.)

Details

Language :
English
ISSN :
1865-7265
Database :
MEDLINE
Journal :
Clinical journal of gastroenterology
Publication Type :
Academic Journal
Accession number :
39117782
Full Text :
https://doi.org/10.1007/s12328-024-02025-7